ProVerum

Healthtech · Dublin, IE

Minimally invasive nitinol-stent solution for benign prostatic hyperplasia

Founders

Ríona Ní Ghriallais (Ireland · ♀) — A biomedical engineer who worked on vascular stent design at Medtronic and Veryan, she co-founded ProVerum in 2016 out of the BioInnovate programme to build a minimally invasive nitinol device for enlarged prostate, as CTO.
Conor Harkin (Ireland · ♂) — A BioInnovate fellow at the University of Galway, he co-founded ProVerum in 2016 to develop a minimally invasive BPH treatment device.

Shares the most investors with (number = shared investors):

Date	Round	Amount
Aug 2025	Series B Dublin medtech ProVerum closed an USD 80m Series B led by MVM Partners, with new investors OrbiMed and ISIF joining alongside Enterprise Ireland and Lightstone Ventures.	$80M
Jan 2022	Series A Dublin medtech ProVerum raised a €30m Series A co-led by Gilde Healthcare Partners and Lightstone Ventures for its prostate-treatment device.	$32.4M
Oct 2021	Grant ProVerum was selected for EIC Accelerator grant-and-equity funding as one of five Enterprise Ireland-backed Irish companies sharing more than €20.5m.	—

Tap an investor to see what else they have backed.

Data is community-curated and may be incomplete.